Avant Brands (AVNT) investor relations material

Executive summary

• Operates four licensed indoor cannabis cultivation facilities with approximately 180 employees and over $41 million in annual sales for F2025.

• Recognized as one of Canada's fastest-growing companies, ranked 138th by Globe & Mail in 2025.

• Distributes through domestic recreational, export, B2B, and medical channels, with a strong brand portfolio targeting diverse consumer segments.

• Export is the fastest-growing sales channel, with high double-digit annual growth and primary markets in Israel, Australia, and Germany.

• Achieved 19% growth in recreational revenue to $14.8 million, driven by blk mkt™ and Tenzo™ brands.

Financial highlights

• F2025 gross sales reached $41.3M, up 3% year-over-year; net sales were $35.9M.

• Adjusted EBITDA for FY2025 was $2.1M, positive in three of four quarters.

• Gross margin (adjusted) for F2025 was $7.7M; gross profit improved to $4.6M, reversing a prior year loss.

• FY2025 net cash flows from operating activities were $5.7M, a record high.

• Net loss reduced by 56% to $9.9M, reflecting operational improvements.

Outlook and guidance

• Actively pursuing additional provincial and territorial markets for recreational sales.

• Focused on expanding export operations, leveraging certifications and facility acquisitions.

• Plans to expand in key European markets and grow international brand licensing partnerships.

• Targeting yield improvements and margin expansion through facility upgrades and lighting installations.

• Evaluating strategic acquisitions in Canada and Europe to accelerate growth.